GAS5 and acute lymphoblastic leukemia: The superior and independent clinical value of GAS5 in chB-ALL was confirmed by the ability of GAS5 overexpression to ameliorate the prognostic accuracy of the established disease markers, including MRD, BM response, and WBC.